Cloverleaf Bio
Healthcare & Life Sci
Company overview
Cloverleaf Bio is an RNA therapeutics company. It is developing a new class of engineered transfer RNA payloads to treat cancer.
The company is headquartered in New Haven, Connecticut, and is a spinout from Yale University. It closed a $33 million seed financing in September 2026.
- Industry
- Healthcare & Life Sci
- Headquarters
- New Haven, United States